AROMICS is a Spain-based biotechnology startup founded in 2005. The company specializes in the development of innovative products, services, and science, with a strategic focus on identifying, selecting, and validating novel molecular biomarkers for various applications. These applications include the development of novel therapies against therapeutic targets, diagnostic tools for drug response prediction and monitoring, and the prediction of drug efficacy, toxicity, and safety profiles. AROMICS offers partnerships to pharmaceutical and biotech companies for the discovery, validation, and development of biomarkers in the context of drug development and diagnosis, aiming to reduce drug development costs and accelerate the R&D process through the integration of OMIC sciences in pharmaceutical development.
There is no investment information
No recent news or press coverage available for AROMICS.
We care about your data, and we'd love to use cookies make your experience better.
